You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Lymphocytic, Chronic, B-Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Loncastuximab Tesirine
  • (no location specified)
Jul 24, 2023

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +5 more
    • (no location specified)
    Jul 21, 2023

    B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
      • Manhasset, New York
        Feinstein Institute for Medical Research
      Jul 6, 2022

      Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

      Recruiting
      • Relapsed or Refractory CD19+ B-cell Lymphoma
      • +2 more
      • TBI-2001
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jul 26, 2023

      Biomarker for Infection Risk in CLL and MM

      Not yet recruiting
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Screening
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      May 3, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Zanubrutinib Pill
      • +2 more
      • New York, New York
        Weill Cornell Medicine/NewYork-Presberteryian Hospital
      Dec 6, 2022

      Understanding Chronic Lymphocytic Leukemia

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Aug 1, 2022

        Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

        Completed
        • Multiple Myeloma
        • Chronic Lymphocytic Leukemia
        • Myeloma Coach or CLL Coach Mobile App
        • Springboard Beyond Cancer informational website
        • Durham, North Carolina
          Duke University
        Jun 23, 2023

        Determination of Blood Tumor Cells

        Completed
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • Abnormalities Cell Epithelial
          • Zurich, Switzerland
            University Hospital Zurich
          Jan 9, 2023

          Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • (no location specified)
          Jul 10, 2023

          Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

          Not yet recruiting
          • Lymphoproliferative Disorders
          • +3 more
          • No intervention
          • (no location specified)
          Jan 30, 2023

          B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

          Suspended
          • B-cell Chronic Lymphocytic Leukemia
          • Alemtuzumab
          • Peking, Beijing, China
            Peking University Cancer Hospital
          Jun 15, 2022

          Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

          Not yet recruiting
          • Relapsed Non-Hodgkin Lymphoma
          • +6 more
          • (no location specified)
          Apr 12, 2023

          Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

          Recruiting
          • CLL/SLL
          • Jinan, Shandong, China
            Department of Hematology, Shandong Provincial Hospital Affiliate
          Jun 16, 2023

          Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

          Recruiting
          • Non-hodgkin Lymphoma
          • +2 more
          • CC312
          • Tianjin, Tianjin, China
            InstituteHBDH
          Sep 12, 2023

          Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

          Active, not recruiting
          • Leukemia, Lymphocytic, Chronic, B-Cell
          • Lymphoma, Non-Hodgkin
          • Copenhagen, Denmark
          • +9 more
          Jan 27, 2023

          B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

          Active, not recruiting
          • Chronic Lymphocytic Leukemia
            • Manhasset, New York
              Feinstein Institute for Medical research
            Jul 6, 2022

            B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

            Not yet recruiting
            • B-cell Non Hodgkin Lymphoma
            • Chronic Lymphocytic Leukemia
            • Cyclophosphamide injection
            • +2 more
            • Charleston, South Carolina
              Hollings Cancer Center at Medical University of South Carolina
            Jan 18, 2023

            ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia

            Not yet recruiting
            • Chronic Lymphocytic Leukemia
              • (no location specified)
              May 7, 2022

              Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

              Not yet recruiting
              • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
                • (no location specified)
                Dec 16, 2022

                Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

                Recruiting
                • Chronic Lymphocytic Leukemia
                • Small Lymphocytic Lymphoma
                • Houston, Texas
                  M D Anderson Cancer Center
                Nov 17, 2022

                Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

                Not yet recruiting
                • Chronic Lymphocytic Leukemia
                • +2 more
                • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
                • +2 more
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Apr 10, 2023

                Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

                Not yet recruiting
                • Relapsed/Refractory Chronic Lymphocytic Leukemia
                • Tianjin, Tianjin, China
                  Institute of Hematology and Blood Diseases Hospital, Chinese Aca
                Jul 13, 2023